Patients n (%) | |
---|---|
N | 148 |
Age (years) | |
Mean | 63.2 |
Median | 65.2 |
Range | 21.1–81.0 |
Sex | |
Female | 58 (39.2) |
Male | 90 (60.8) |
Location | |
Esophagus | 62 (41.9) |
Stomach | 86 (58.1) |
cT stage | |
T1 | 1 (0.7) |
T2 | 54 (36.5) |
T3 | 87 (58.8) |
T4 | 6 (4.1) |
cN stage | |
N0 | 80 (54.1) |
N1 | 50 (33.8) |
N2 | 14 (9.5) |
N3 | 4 (2.7) |
cM stage | |
M0 | 136 (91.9) |
M1 | 12 (8.1) |
Lymph node metastasis in M1-position | 6 |
Liver metastasis | 3 |
Adrenal gland metastasis | 1 |
Ovarian metastasis | 1 |
Ascites | 1 |
Neoadjuvant treatment | |
Chemotherapy NOS | 148 |
Fluoropyrimidine + platinum ≥ 8 weeks, no irinotecan | 121 (81.8) |
Resection | |
Yes | 118 (79.7) |
No | 30 (20.3) |
Peroperative findings of advanced disease | 20 |
Liver metastasis found after one cycle of chemotherapy | 1 |
Progressive disease | 1 |
Deteriorated performance status | 3 |
Death | 2 |
Patient’s wish | 3 |
Adjuvant treatment | |
Chemotherapy NOS | 78 (66.7) |
Fluoropyrimidine + platinum ≥ 8 weeks, no irinotecan | 46 |
Chemoradiotherapy | 10 (8.5) |
None | 29 (24.8) |
Missing data | 1 |
No surgery | 30 |
Histopathologic response | |
0% residual cancer cells | 13 (11.1) |
1–10% | 13 (11.1) |
11–50% | 46 (39.3) |
> 50% | 45 (38.5) |
Missing data | 1 |
No surgery | 30 |
ypT stage | |
T0 | 13 (11.1) |
T1 | 14 (12.0) |
T2 | 22 (18.8) |
T3 | 42 (35.9) |
T4 | 26 (22.2) |
Missing data | 1 |
No surgery | 30 |
ypN stage | |
N0 | 52 (44.1) |
N1 | 28 (23.7) |
N2 | 18 (15.3) |
N3 | 20 (16.9) |
No surgery | 30 |
ypM stage | |
M0 | 113 (95.8) |
M1 | 5 (4.2) |
Lymph node metastasis in M1-position | 1 |
Liver metastasis | 1 |
Ovarian metastasis | 1 |
Peritoneal deposit | 2 |
No surgery | 30 |
Residual tumor status | |
R0 | 97 (82.2) |
R1 | 19 (16.1) |
R2 | 2 (1.7) |
No surgery | 30 |
Number of examined lymph nodes | |
Mean | 36 |
Median | 35 |
Range | 4–88 |
Differentiation grade | |
Low grade | 3 (2.4) |
Intermediate grade | 52 (42.3) |
High grade | 68 (55.3) |
Missing data | 25 |
Lauren classification | |
Intestinal | 65 (52.8) |
Mixed | 16 (13.0) |
Diffuse | 42 (34.1) |
Missing data | 25 |
Follow-up resected patients (years) | |
Median (95% CI) | 5.8 (5.2–6.4) |